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ABSTRACT 
	
Background:	The	aim	of	this	study	is	to	investigate	whether	preoperative	coagulation	
profile	 is	 predictive	 of	 outcome	 in	 patients	 undergoing	 endovascular	 aortic	 repair	
(EVAR)	for	ruptured	abdominal	aortic	aneurysms	(RAAAs).	
	
Methods:	Consecutive	patients	undergoing	EVAR	for	RAAA	between	March	2010	and	
December	2016	were	recruited	from	a	single	vascular	unit.	Patient	details,	including	
fibrinogen	levels,	platelets	count,	aPTT	and	INR	levels	on	admission	were	extracted	
from	case	files.	Major	outcomes	were	recorded	as:	30-day	mortality,	mortality	overall,	
major	adverse	cardiovascular	events	(MACE),	endoleaks	and	interventions.	We	used	
t-test	to	examine	for	potential	associations.	
	
Results:	 Thirty	 patients	 (29	 males,	 mean	 72.9	 years),	 all	 with	 available	 initial	
coagulation	screening	were	included	in	this	series.	Four	patients	died	within	30	days	
after	the	procedure	(13.3%)	and	a	further	2	died	from	unrelated	causes	during	the	
follow-up	 (median	 8	 months),	 raising	 the	 overall	 mortality	 to	 20%.	 Ten	 patients	
suffered	a	MACE	(33.3%),	8	had	an	endoleak	(26.7%)	and	5	required	an	aneurysm-
related	re-intervention	(16.7%).	Presenting	fibrinogen	levels	and	platelets	count	were	
significantly	higher	in	the	group	of	patients	surviving	30	days	compared	to	the	fatal	
cases	(p=0.044;	p=0.022),	as	well	as	in	those	without	an	endoleak	compared	to	those	
with	 an	 endoleak	 (p=0.001;	 p=0.028).	 Higher	 presenting	 platelets	 count	 were	
significantly	associated	with	lower	overall	mortality	rates	(p=0.026)	whereas	patients	
with	higher	INR	levels	had	significantly	more	re-interventions	(p=0.044).		
	
Conclusions:	 In	 this	 small	 series	 of	 EVAR	 for	 RAAAs,	 a	 potential	 preoperative	
hypercoagulable	 profile	 with	 higher	 fibrinogen	 levels	 and	 platelets	 count	 may	 be	
associated	with	better	chances	of	early	survival	and	a	lower	probability	of	an	endoleak	
at	 follow-up.	 Further	 studies	 are	 needed	 to	 clarify	 this	 issue	 and	 possible	 future	
therapeutic	 implications,	 for	 example,	 whether	 outcome	 can	 be	 improved	 by	
technically	 increasing	 fibrinogen	 levels	 along	 with	 the	 administration	 of	 blood	
products,	as	soon	as	the	diagnosis	of	RAAA	is	made.	 	
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ΠΕΡΙΛΗΨΗ 
	
Εισαγωγή:	Σκοπός	αυτής	της	μελέτης	είναι	η	πιθανή	πρόβλεψη	της	έκβασης	με	βάση	
το	προεγχειρητικό	πηκτικό	προφίλ,	σε	ενδαγγειακή	αποκατάσταση	(EVAR)	ραγέντος	
ανευρύσματος	κοιλιακής	αορτής	(ΡΑΚΑ).	
	
Μέθοδοι:	 Συμπεριλήφθηκαν	 διαδοχικοί	 ασθενείς	 κατά	 το	 διάστημα	 μεταξύ	 του	
Μαρτίου	του	2010	έως	Δεκέμβρη	του	2016	από	μία	αγγειοχειρουργική	κλινική.	Από	
τους	ιατρικούς	του	φακέλους	καταγράφηκαν	λεπτομέρειες	σχετικά	με	τους	ασθενείς,	
συμπεριλαμβανομένων	 των	 προεγχειρητικών	 τιμών	 ινωδογόνου,	 αιμοπεταλίων,	
aPTT	και	INR	κατά	την	εισαγωγή	τους.	Τα	σημαντικά	αποτελέσματα	ήταν:	η	άμεση	
θνητότητα	 (30	 ημερών),	 συνολική	 θνητότητα,	 κύρια	 δυσμενή	 καρδιαγγειακά	
συμβάντα	 (ΔΥΚΑΣ),	 ενδοδιαφυγές	 και	 επανεπεμβάσεις.	 Για	 τη	 διερεύνηση	 των	
πιθανών	σχέσεων	χρησιμοποιήθηκε	το	t-test.	
	
Αποτελέσματα:	Τριάντα	ασθενείς	(29	άντρες,	μέση	ηλικία=72.9	έτη)	συμμετείχαν	στη	
μελέτη.	Τέσσερις	ασθενείς	απεβίωσαν	τις	πρώτες	30	μετεγχειρητικές	ημέρες	(13.3%),	
ενώ	 2	 ακόμη	 κατέληξαν	 από	 μη	 σχετιζόμενα	 αίτια	 (20%)	 κατά	 τη	 διάρκεια	 της	
παρακολούθησης	(διάμεσος=8	μήνες).	Δέκα	ασθενείς	υπέστησαν	ΔΥΚΑΣ	(33.3%),	8	
βρέθηκαν	 με	 ενδοδιαφυγή	 (26.7%)	 και	 5	 χρειάστηκαν	 επανεπέμβαση	 (16.7%).	 Οι	
προεγχειρητικές	 τιμές	 ινωδογόνου	 και	 αιμοπεταλίων	 ήταν	 σημαντικά	 υψηλότερες	
στους	επιζήσαντες	σε	σχέση	με	τους	θανόντες	κατά	τις	30	πρώτες	ημέρες	(p=0.044;	
p=0.022),	καθώς	επίσης	και	στους	ασθενείς	χωρίς	ενδοδιαφυγή	(p=0.001;	p=0.028).	
Σημαντικά	χαμηλότερα	ποσοστά	συνολικής	θνητότητας	παρουσίασαν	οι	ασθενείς	με	
υψηλότερες	τιμές	αιμοπεταλίων	κατά	την	εισαγωγή	τους	(p=0.026),	ενώ	στατιστικά	
σημαντική	 συσχέτιση	 βρέθηκε	 μεταξύ	 των	 υψηλότερων	 τιμών	 INR	 και	 των	
επανεπεμβάσεων	(p=0.044).		
	
Συμπέρασμα:	 Σε	 αυτή	 τη	 μικρή	 σειρά	 ασθενών	 με	 EVAR	 για	 ΡΑΚΑ,	 πιθανόν	 ένα	
προεγχειρητικό	 υπερπηκτικό	 προφίλ,	 με	 υψηλά	 επίπεδα	 ινωδογόνου	 και	
αιμοπεταλίων,	να	συνδέεται	με	περισσότερες	πιθανότητες	άμεσης	επιβίωσης	καθώς	
και	λιγότερες	πιθανότητες	εμφάνισης	ενδοδιαφυγής	μετεγχειρητικά.	Μεγαλύτερες	
και	 περισσότερες	 μελέτες	 απαιτούνται	 για	 τη	 διερεύνηση	 του	 ζητήματος	 της	
συσχέτισης,	 καθώς	 και	 για	 πιθανές	 μελλοντικές	 θεραπευτικές	 επιλογές	 όπως	 η	
ενδεχόμενη	τεχνητή	αύξηση	των	επιπέδων	ινωδογόνου	ταυτόχρονα	με	τη	χορήγηση	
προϊόντων	αίματος,	με	τη	διάγνωση	της	ρήξης.	 	
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INTRODUCTION 
	
Abdominal	aortic	aneurysm	is	a	dilatation	of	the	aorta	more	than	50%	of	the	diameter.	
Progression	 and	 enlargement	 of	 the	 aneurysm	 can	 lead	 to	 rupture	 and	 massive	
internal	bleeding.	Ruptured	abdominal	aortic	aneurysm	(RAAA)	is	a	lethal	condition	
and	 remains	with	 high	 rates	 of	morbidity	 and	mortality	 of	 around	 50%.	 [4,6-8,14]	
Overall	 population	 mortality	 is,	 however,	 much	 higher	 reaching	 rates	 of	 80-90%,	
because	less	than	half	of	the	patients	reach	hospital	alive.	[2,15]	Open	repair	(OR)	was	
the	standard	treatment	of	RAAAs	for	more	than	50	years,	however	during	the	last	two	
decades	EVAR	has	been	used	around	the	world	with	equal	results.	[13]		
EVAR	was	first	described	in	1991	by	Parodi	et	al	and	Volodos	et	al,	and	brought	a	
revolution	in	the	minimal	invasive	approach	to	elective	AAAs.	[16-18]	Not	many	years	
later,	 in	 1994,	 EVAR	 was	 used	 as	 potential	 treatment	 for	 RAAAs	 as	 well	 (rEVAR)	
[19,20],	and	nowadays	has	been	promoted	as	treatment	of	choise.	[21]		
Several	 studies	 have	 compared	 emergency	 OR	 with	 rEVAR	 for	 RAAA.	 Several	
observational	 studies	 indicated	 potential	 better	 30-day	 survival	 and	 complication	
rates	 following	 EVAR	 for	 RAAA	 comparing	 to	 OR,	 but	 no	 significant	 differences	 in	
overall	mortality.	[5,9,11]	However,	other	studies	and	a	randomized	controlled	trial,	
did	not	prove	inferiority	of	EVAR	over	OR	for	RAAAs	and	elective	AAAs.	[10,12]		
Further	studied	need	to	be	done,	to	investigate	potential	preoperative	factors	that	
may	 influence	 survival	 and	 improve	 outcome	 in	 EVAR.	 Our	 hypothesis	 is	 that	
coagulation	 profile	 factors,	 comprising	 fibrinogen	 levels,	 platelets	 (PLT)	 count,	
activated	partial	thromboplastin	time	(aPTT)	and	international	normalized	ratio	(INR)	
levels	on	admission,	might	be	potential	biomarkers	predictors	of	outcome	(early	or	
overall)	in	RAAA	patients	undergoing	EVAR.	Increase	in	levels	of	these	factors	may	be	
associated	with	 a	hypercoagulable	 state,	which	might	be	protective	 in	RAAAs,	 and	
therefore	immediate	access	to	coagulation	status,	as	soon	as	the	diagnosis	is	made,	
will	be	very	useful.	The	aim	of	this	retrospective	observational	study	is	to	investigate	
potential	 association	 between	 preoperative	 coagulation	 profile	 and	 outcome	 in	
patients	treated	with	EVAR	for	RAAA.	
	
	
METHODS AND MATERIALS 
	
Study	design	
During	the	study	period	1	March	2010	and	31	December	2016	consecutive	patients	
undergoing	EVAR	for	RAAA	were	enrolled	 in	this	retrospective	observational	study.	
The	study	was	held	in	a	single	vascular	unit	based	on	a	tertiary	university	hospital	that	
provided	 on-call	 vascular	 services	 for	 northern	 Greece	 every	 fourth	 day.	 Our	 unit	
started	 operating	 electives	 EVAR	 back	 in	 1995,	 and	 established	 EVAR	 protocol	 for	
RAAA	in	early	1998	[1,2],	therefore	our	surgeons	have	gained	a	lot	of	experience	in	
the	field,	being	among	the	first	to	operate	EVAR	for	RAAA	in	Greece.	[2,3]	Surveillance	
and	follow-up	consisted	of	abdomen	X-rays	and	CT	scans	before	discharge,	at	1,	3,	6	
and	12	months	and	annually	thereafter	for	the	remaining	lifetime	of	the	patient.	The	
study	did	not	require	formal	ethical	approval	by	the	Hospital	Ethical	Committee	and	
in	 all	 cases,	 relatives	 and	when	possible	 the	 patients	 themselves,	 signed	 informed	
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consent	form	prior	to	the	operation,	after	discussion	of	the	severity	of	their	condition,	
poor	prognosis	and	possible	complications.	
During	the	study	period,	a	total	of	53	patients	were	diagnosed	for	RAAA	and	treated	
with	EVAR.	Twenty-three	patients	were	excluded	due	to	lack	of	records	from	case	files	
or	 inadequate	 presenting	 coagulation	 profile	 screening.	 Therefore,	 30	 patients	
enrolled	 in	 this	 study	 and	 no	 one	 denied	 intervention	 for	 logistic	 reasons.	 Patient	
details	were	extracted	from	case	files	and	 information	was	gathered	from	medical,	
nursing,	 medication	 and	 emergency	 department’s	 records.	 Demographic	 data	
comprised	 age,	 sex,	 date	 of	 admission	 and	 past	 medical	 history	 records	 included	
cardiac	 disease,	 hypertension,	 chronic	 obstructive	 pulmonary	 disease	 (COPD),	
cerebrovascular	 disease	 (CVD),	 diabetes	 mellitus	 history,	 smoking	 status,	 hostile	
abdomen	and	history	of	previous	EVAR	 (elective	or	 rupture).	Other	 factors	 contain	
duration	of	 symptoms,	presenting	systolic	blood	pressure,	 lowest	 recorded	systolic	
blood	pressure,	 loss	of	 consciousness,	hemodynamic	 instability,	 type	of	 anesthesia	
and	aneurysm	morphological	characteristics.	Hemoglobin,	serum	creatinine	levels	and	
coagulation	 profile	 values	 on	 admission,	 including	 preoperative	 fibrinogen	 levels,	
platelets	count,	activated	partial	thromboplastin	time,	international	normalized	ratio	
levels,	were	recorded	from	laboratory	database.	
	
Procedure	details	
As	soon	as	rupture	was	suspected	in	the	emergency	room,	the	patient	was	brought	
straight	 to	 the	 radiology	 department,	 for	 a	 computed	 tomography	 scan	 (CT).	 The	
duration	of	the	whole	procedure	did	not	last	more	than	30	minutes	totally.	However,	
when	rupture	was	identified	and	diagnosed	via	CT	by	a	referring	peripheral	hospital,	
patient	was	transferred	immediately	to	the	operating	room	bypassing	the	emergency	
department	(ED).	Diagnosis	and	evaluation	of	a	suspected	RAAA	was	set	by	contrast-
enhanced	spiral	CT	with	5mm	slices	and	was	assessed	by	the	on-call	radiologist	and	
vascular	surgeon.	The	decision	to	proceed	to	EVAR	or	open	repair	(OR)	was	made	by	
the	 on-call	 vascular	 expert,	 according	 to	 their	 judgement.	 EVAR	 is	 the	 preferred	
method	 of	 repair	 in	 our	 center,	 however	 complexity	 of	 anatomy,	 personal	
competence	and	expertise	in	performing	advanced	EVAR	and	hospital	resources,	were	
all	contributing	factors	upon	deciding	the	method	of	repair.	Anatomic	criteria	for	EVAR	
in	RAAA	patients	did	not	differ	from	criteria	in	an	elective	repair,	the	most	important	
of	them	being	that	the	infrarenal	neck	should	have	a	length	of	at	least	10mm.	There	
were	no	specific	inclusion	or	exclusion	criteria,	according	to	the	hemodynamic	state	
of	the	patient.	With	gaining	experience	and	expertise	throughout	the	years,	more	and	
more	challenging	cases	were	treated	with	endovascular	means	in	our	unit,	leading	to	
the	expansion	of	selection	criteria,	both	for	ruptured	EVAR	(rEVAR)	and	elective	repair.		
When	the	decision	was	made	about	the	type	of	the	intervention	and	the	patient	
was	 considered	 suitable	 for	 EVAR,	 they	 were	 transferred	 in	 a	 dedicated	 hybrid	
vascular	operation	room,	both	for	endovascular	and	open	procedures.	Since	a	vascular	
interventional	radiologist	was	not	available	 in	our	hospital,	all	endovascular	 repairs	
are	performed	by	the	on-call	vascular	team,	consisting	of	one	vascular	specialist	and	
two	 vascular	 trainees.	 The	 surgery	 was	 usually	 done	 under	 local	 anesthesia	 and	
intravenous	 sedation	 was	 administrated,	 when	 needed,	 to	 minimize	 patient	
movement	 and	 discomfort.	 General	 anesthesia	was	 chosen	 in	 cases	where	 severe	
hypovolemia	caused	loss	of	consciousness	or	patency	of	airway	was	under	threat.	All	
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patients	 were	 under	 close	 monitoring	 by	 the	 anesthesiologist,	 throughout	 the	
intervention.	Intravenous	fluid	and	blood	resuscitation	were	kept	to	a	minimum	until	
aneurysm	exclusion,	to	achieve	a	systolic	blood	pressure	goal	of	80-100	mmHg.	Access	
to	the	common	femoral	arteries	was	gained	by	bilateral	skin	incisions	in	the	groins	and	
suitably	sized	sheaths	were	used	to	cannulate	the	femoral	arteries.	Our	endovascular	
facilities	 include	 a	 mobile	 C-ARM	 image	 intensifier	 to	 perform	 EVAR	 and	 other	
endovascular	 interventions.	 In	 cases	 of	 profound	 intra-operative	 hemodynamic	
instability,	an	aortic	occlusion	balloon	was	used	selectively	to	prevent	exsanguination.	
The	most	important	factor	for	the	selection	of	the	stent	graft	was	device	availability,	
as	well	as	surgeon’s	preference,	expertise	and	aneurysm	anatomic	and	morphological	
characteristics.	Access	to	stent	grafts	was	through	local	company	representatives.	
	
Inclusion	Criteria	
Every	patient	with	diagnosed	RAAA	via	CT,	defined	by	International	Classification	of	
Diseases	 (ICD)	 10	 codes	 and	 treated	 with	 EVAR	 during	 this	 study	 analysis,	 were	
enrolled	 in	 the	 study.	 Inclusion	 criteria	 comprised	 only	 patients	 with	 available	
presenting	 laboratory	 values	 concerning	 coagulation	 profile	 and	 those	 who	 were	
treated	with	endovascular	means.	Therefore,	patients	without	initial	ED	coagulation	
screening,	those	who	underwent	endovascular	repair	but	switched	to	open,	or	those	
who	were	treated	with	open	repair	(OR)	 in	the	first	place,	were	excluded	from	this	
analysis.	
	
Outcomes	and	Definitions	
Primary	outcome	measures	were	30-day	mortality,	summarizing	the	rate	of	deaths	in	
the	first	30	postoperative	days	and	overall	mortality,	which	included	the	rate	of	fatal	
cases	from	all-cause	mortality,	throughout	the	follow-up	period.	Secondary	outcomes	
measures	 comprised	 endoleaks,	 major	 adverse	 cardiovascular	 events	 (MACE)	 and	
aortic-related	re-intervention.	MACE	was	defined	as	lower	limb	amputation,	ischemic	
coronary	disease	(i.e.	MI),	cerebrovascular	disease	(stroke	or	TIA),	aneurysm-related	
morbidity	and/or	re-intervention	and	all-cause	mortality	as	a	composite	end-point.	
Hemodynamic	 instability	 was	 used	 to	 describe	 every	 patient	 with	 hypotension	
(systolic	blood	pressure	£	80	mmHg)	and/or	loss	of	consciousness	at	any	time	before	
the	repair.	Duration	of	symptoms	was	defined	as	the	time	passed	since	the	onset	of	
the	first	clinical	sign	of	rupture	(i.e.	pain,	loss	of	consciousness,	etc.),	until	the	moment	
patients	entered	the	operating	room.	Lastly,	 the	term	hostile	abdomen	includes	all	
kind	of	operations	and	interventions	in	the	area	of	the	abdomen,	including	previous	
EVAR	(elective	or	urgent).	
	
Statistical	analysis	
All	statistical	analysis	was	performed	using	the	IBM®	SPSS®	Statistics	software,	Version	
23	 for	 macOS	 (IBM	 Corp.).	 Continuous	 descriptive	 data	 are	 presented	 as	 mean	 ±	
standard	deviation	(range)	or	median	(25th	percentile	[Q1]	to	75th	percentile	[Q3])	for	
non-normally	distributed	data,	as	appropriate.	Categorical	variables	are	presented	as	
No.	 (percentage	of	 total	 [%]).	Continuous	data	were	 tested	 for	normal	distribution	
using	Shapiro-Wilk’s	test.		
Descriptive	 comparisons	of	 continuous	data	were	performed	using	 t-test	or	 the	
Mann-Whitney	U	test,	as	required,	whereas	categorical	variables	were	compared	with	
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chi-square	(x2)	test.	We	performed	univariate	analysis	between	major	outcomes	and	
data	describing	coagulation	profile.	However,	we	were	not	able	to	analyze	data	using	
binary	 logistic	 regression,	 because	 of	 the	 limited	 number	 of	 enrolled	 subjects.	
Statistical	significance	level	was	set	to	a	p-value<0.05.		
	
	
RESULTS 
	
A	total	of	thirty	patients	(29	males,	1	female)	with	mean	age	72.9	years	(range=33,	55-
88	years)	underwent	EVAR	for	RAAA	during	this	study	period.	Demographic	details,	
patients’	medical	history,	presenting	clinical	features	and	laboratory	values,	as	well	as	
details	regarding	the	surgical	procedure	are	summarized	on	Table	1.	Cardiac	disease	
history,	 including	coronary	artery	disease,	cardiac	 failure	and	atrial	 fibrillation,	was	
recorded	in	53.3%	of	patients,	while	more	than	60%	of	them	were	under	treatment	
for	 hypertension	 and	 were	 active	 or	 ex-smokers.	 Chronic	 obstructive	 pulmonary	
disease	was	observed	in	43.3%	of	study	population,	10%	had	cerebrovascular	disease	
history,	 including	 transient	 ischemic	 attack	 (TIA)	 or	 stroke,	 and	30%	of	 them	were	
diabetic.	As	far	as	surgical	history	is	concerned,	a	significant	percentage	of	50%	had	
hostile	abdomen,	8	out	of	30	patients	(26.7%)	had	undergo	previous	EVAR	(5	had	an	
elective	EVAR	and	3	had	EVAR	for	RAAA)	and	only	1	had	been	treated	with	open	repair	
(3.3%).		
The	 median	 duration	 of	 symptoms,	 until	 the	 moment	 patient	 arrived	 at	 the	
hospital,	was	18	hours	(Q1-Q3=21).	Four	patients	(13.3%)	arrived	with	systolic	blood	
pressure	(SBP)	below	80	mmHg,	and	the	mean	presenting	SBP	was	111.7	(range=150,	
30mmHg-180	mmHg).	Eight	patients	(26.7%)	lost	their	consciousness,	at	least	once,	
prior	or	after	arriving	to	the	emergency	department	and	approximately	half	of	them	
(46.7%)	 presented	 or	 became	 hemodynamically	 unstable	 during	 the	 preoperative	
management.	
Laboratory	values	 included	a	mean	PLT	count	225.1	 (range=292,	109-401x109/L)	
and	 mean	 fibrinogen	 levels	 411.3	 (range=808,	 133-941	 mg/dL).	 Coagulation	
mechanism	was	represented	by	a	median	 INR	1.15	(Q1-Q3=0.22)	and	median	aPTT	
30.1	sec	(Q1-Q3=7.87	sec).	Mean	hemoglobin	(Hb)	value	was	11.1	g/dL	(range=7,	8-
15	g/dL)	and	median	serum	creatinine	levels	was	1.31	mg/dL	(Q1-Q3=0.86	mg/dL).	
Seventy	percent	of	the	patients	during	this	study	period	had	a	de	novo	RAAA	and	
the	mean	aneurysm	diameter	was	8.1	cm	(range=8,	4-12	cm).	De	novo	RAAAs	were	
treated	 with	 16	 bifurcated	 stent	 grafts,	 3	 aortouniiliac	 endografts	 with	 femoro-
femoral	crossover	bypass	and	2	ruptured	aneurysms	were	treated	with	tube	endograft	
combined	 with	 the	 chimney-periscope	 technique.	 Twenty-seven	 patients	 (90%)	
underwent	 the	 procedure	 with	 local	 anesthetic	 in	 the	 groins,	 whereas	 general	
anesthesia	was	used	in	only	three	patients	(10%).	
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Table	1:	Descriptive	data	
Variable	 No.	(%)	or		mean/median	(range/Q1-Q3)	
Total	 30	(100%)	
	 	
Demographic	details	 	
					Sex	 	
	 Males	 29	(96.7%)	
	 Females	 1	(3.3%)	
					Age	(years)	 72.9	(33)	
Medical	history	 	
					History	of	cardiac	disease	 16	(53.3%)	
					Hypertension	 19	(63.3%)	
					Smokers	(current	or	ex)	 20	(66.7%)	
					COPD	 13	(43.3%)	
					CVD	(stroke	or	TIA)	 3	(10%)	
					Diabetes	 9	(30%)	
					Hostile	abdomen	 15	(50%)	
					Previous	EVAR	 8	(26.7%)	
Elective		 5	(16.6%)	
rEVAR	 3	(10%)	
					Previous	open	repair	 1	(3.3%)	
Presenting	clinical	features	 	
					Duration	of	symptoms	(hours)	 18	(21)	
					Presenting	SBP	(mmHg)	 111.7	(150)	
					Presenting	SBP	£	80	mmHg	 4	(13.3%)	
					Lowest	measured	SBP	(mmHg)	 88	(100)	
					Loss	of	consciousness	 8	(26.7%)	
					Hemodynamic	instability	(SBP	£	80	mmHg±	
					loss	of	consciousness)	 14	(46.7%)	
Laboratory	values	on	admission	 	
					PLT	count	(x109/L)	 225.1	(292)	
					aPTT	(sec)	 30.1	(7.87)	
					INR		 1.15	(0.22)	
					Fibrinogen	(mg/dL)	 411.3	(808)	
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 03:00:48 EEST - 137.108.70.13
MSc	Thesis	 Coagulation	profile	and	outcome	of	rEVAR	
September	2017	 Aristotelis	Yfantis,	MD	
-	8	-	
	
					Hb	(g/dL)	 11.1	(7)	
					Serum	Creatinine	(mg/dL)	 1.31	(0.86)	
Surgery	and	aneurysm-related	details	 	
					Anesthesia	 	
	 General	 3	(10%)	
	 Local	 27	(90%)	
					Diameter	(cm)	 8.1	(8)	
					De	novo	rupture	 21	(70%)	
COPD:	 chronic	 obstructive	pulmonary	disease;	 CVD:	 cerebrovascular	 disease;	 TIA:	 transient	 ischemic	
attack;	 EVAR:	 endovascular	 aneurysm	 repair;	 rEVAR:	 ruptured	 endovascular	 aneurysm	 repair;	 SBP:	
systolic	blood	pressure;	PLT:	platelets;	aPTT:	activated	partial	thromboplastin	time;	INR:	international	
normalized	ratio;	Hb:	hemoglobin	
	
Major	outcomes	
Major	outcomes	are	summarized	on	Table	2,	along	with	univariate	analysis	between	
the	major	outcomes	and	coagulation	profile	 in	patients	undergoing	EVAR	for	RAAA	
during	this	study	period.	Four	patients	(13.3%)	died	during	the	first	30	postoperative	
days,	 two	of	 them	 intraoperatively	due	 to	exsanguination	causing	cardiac	asystole.	
The	other	two	died	in	the	first	24	hours	after	the	procedure	in	the	intensive	care	unit	
(ICU),	 due	 to	multiple	organ	 failure.	 The	patients	 received	 large	 amounts	of	 blood	
transfusion,	blood	products	as	well	as	inotropes,	however	they	never	recovered	from	
the	severe	hypovolemic	shock,	as	result	of	the	massive	bleeding.	
During	a	median	follow	up	period	of	8	months	(Q1-Q3=17.7	months),	 two	more	
patients	died	from	unrelated	causes,	 raising	the	overall	mortality	rate	to	20%.	One	
patient	died	from	cardiorespiratory	failure	on	4	months	follow	up,	whereas	the	other	
died	on	11	months	from	pancreatic	cancer.	
Eight	patients	developed	endograft	endoleak	 in	the	follow-up	period	(26.7%).	 In	
detail,	five	of	them	had	type	Ia,	one	type	Ib,	one	type	II	and	lastly	one	came	with	type	
III	endoleak.	Thirty	three	percent	of	enrolled	patients	suffered	from	MACE	(no=10).	
Details	about	MACE	are	thoroughly	described	on	Table	3.	Lastly,	five	patients	(16.7%)	
underwent	 aneurysm-related	 re-intervention.	 In	 detail,	 one	 patient	 underwent	 re-
intervention	for	type	Ib,	two	patients	were	treated	with	aortic	cuff	for	type	Ia	and	one	
for	type	III	and	one	more	was	headed	to	the	theater	due	to	proximal	endograft	limb	
retraction	that	was	successfully	treated	with	right	iliac	endograft	limb	extension.	
	
Table	2:	Univariate	association	between	major	outcomes	and	coagulation	profile	
Major	Outcomes	 No.	(%)	 p-value	
	 	 Fib	 PLT	 aPTT	 INR	
30-Day	mortality	 4	(13.3%)	 0.044	 0.022	 0.154	 0.6	
Overall	mortality	 6	(20%)	 0.3	 0.026	 0.352	 0.979	
Endoleak	 8	(26.7%)	 0.001	 0.028	 >0.99	 0.011	
MACE	 10	(33.3%)	 0.276	 0.862	 0.196	 0.573	
Re-intervention	 5	(16.7%)	 0.853	 0.655	 0.25	 0.044	
	 	 	 	 	 	
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 03:00:48 EEST - 137.108.70.13
MSc	Thesis	 Coagulation	profile	and	outcome	of	rEVAR	
September	2017	 Aristotelis	Yfantis,	MD	
-	9	-	
	
	 	 mean/median	
	 	 Fib	(mg/dL)	 PLT	(x109/L)	 aPTT	(sec)	 INR	
30-Day	mortality	 	 	 	 	
					survivors	vs	fatal	cases	 436	vs	253	 237.5	vs	151	 30.6	vs	25.7	 1.15	vs	1.3	
Overall	mortality	 	 	 	 	
					survivors	vs	fatal	cases	 428	vs	346	 240.5	vs	169	 30.6	vs	27	 1.16	vs	1	
Endoleak	 	 	 	 	
					no	vs	yes	 470	vs	249	 243.5	vs	179	 30.3	vs	30	 1.1	vs	1.3	
MACE	 	 	 	 	
					no	vs	yes	 436	vs	362.5	 227	vs	222	 31.5	vs	29	 1.15	vs	1.16	
Re-intervention	 	 	 	 	
					no	vs	yes	 414	vs	398	 222	vs	238	 29.8	vs	30.4	 1.12	vs	1.2	
MACE:	Major	adverse	cardiovascular	events;	Fib:	fibrinogen;	PLT:	platelets;	aPTT:	activated	partial	
thromboplastin	time;	INR:	international	normalized	ratio	
	
Table	3:	Major	adverse	cardiovascular	events	
MACE	 No.	
Total	 10	
	 	
Intra-op	death	 4	
MI	–	3months	post-op	 1	
Left	endograft	limb	occlusion	-	right	to	left	femoro-femoral	cross	
over	bypass	-	wound	infection	and	left	AKA	–	1	week	post-op	
1	
Proximal	aortic	cuff	–	14months	follow-up	 1	
Death	from	cardiorespiratory	failure	–	4months	follow-up	 1	
Aortic	cuff	for	type	3	endoleak	 1	
SFA	occlusion	causing	claudication	 1	
Intra-op:	 intraoperative;	 MI:	 myocardial	 infraction;	 AKA:	 above	 knee	 amputation;	 post-op:	
postoperative;	SFA:	superficial	femoral	artery	
	
Primary	outcomes	
According	to	our	univariate	analysis,	fibrinogen	levels	were	significantly	higher	in	the	
group	 of	 survivors	 compared	 to	 fatal	 cases	 during	 the	 first	 30	 postoperative	 days	
(mean	 ±	 SD:	 436±167	mg/dL	 vs	 238±107	mg/dL;	 p=0.044)	 (Figure	 1).	 Preoperative	
platelets	 count	 also	differed	 significantly	 between	 the	 two	groups,	 being	higher	 in	
survivors	(mean	±	SD:	237.5±69	vs	151±29.6;	p=0.022)	(Figure	2).	However,	aPTT	and	
INR	were	not	found	to	be	significantly	associated	with	early	survival.	
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Figure	1:	Boxplot	of	pre-op	fibrinogen	levels	in	survivors	and	fatal	cases	in	the	first	30	post-op	days.	
	
	
Figure	2:	Boxplot	of	pre-op	platelets	count	in	survivors	and	fatal	cases	during	the	first	30	post-op	days.	
	
After	 this	 early	 30-day	 period	 of	 close	 follow-up,	 only	 PLT	 count	 seemed	 to	 be	
significantly	associated	with	overall	mortality.	Platelets	count	remained	significantly	
higher	in	those	who	survived	during	the	median	follow-up	of	8	months	in	comparison	
to	the	fatal	cases	(mean	±	SD:	240.5±71	vs	169±36;	p=0.026)	(Figure	3).	Fibrinogen	
levels,	as	well	as	aPTT	and	 INR	were	not	significantly	different	between	those	who	
survived	and	died	overall.		
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Figure	3:	Boxplot	of	pre-op	platelets	count	of	overall	survivors	and	fatal	cases.	
	
Secondary	outcomes	
Preoperative	 fibrinogen	 levels,	 platelets	 count	 and	 INR	 seemed	 to	 be	 significantly	
associated	 with	 endoleak	 after	 EVAR	 procedure	 for	 RAAA	 in	 this	 small	 series.	
Fibrinogen	levels	and	platelets	count	on	admission	were	higher	in	those	without	an	
aortic	related	endoleak	compared	to	those	who	developed	one	(mean	±	SD:	470±155	
vs	 249±87;	 p=0.001)	 (mean	 ±	 SD:	 243.5±68	 vs	 179±61;	 p=0.028)	 (Figures	 4,5).	
Contrary,	INR	was	significantly	low	in	patients	without	and	endoleak	(median	1.1	vs	
1.3;	p=0.011)	(Figure	6),	and	only	aPTT	did	not	differ	significantly	between	the	two	
groups.		
	
Figure	4:	Boxplot	of	pre-op	fibrinogen	levels	in	patients	with	and	without	an	endoleak.	
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Figure	5:	Boxplot	of	pre-op	platelets	count	in	patients	with	and	without	an	endoleak.	
	
	
Figure	6:	Boxplot	of	pre-op	INR	levels	in	patients	with	and	without	an	endoleak.	
	
The	preoperative	variables	of	patients’	coagulation	profile	we	chose	to	analyze,	did	
not	have	any	statistically	significant	difference	between	patients	who	suffered	from	
MACE	and	those	who	did	not,	during	the	follow-up.		
Preoperative	INR	levels	were	slightly	significant	higher	in	patients	who	underwent	
re-intervention	for	aneurysm	related	complications,	compared	to	patients	free	of	re-
intervention	(median:	1.2	vs	1.12;	p=0.044)	(Figure	7).	Presenting	fibrinogen,	platelets	
and	aPTT	values	did	not	seem	to	be	associated	with	re-intervention.	
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Figure	7:	Boxplot	of	pre-op	INR	levels	in	patients	with	and	without	an	aneurysm	related	re-
intervention.		
	
	
DISCUSSION 
	
Admiring	advances	have	been	made	 in	surgical	and	anesthetic	 techniques	over	the	
last	decades,	in	the	management	of	acute	surgical	conditions,	such	as	RAAA.	However,	
perioperative	morbidity	and	mortality	rates	remain	high	reaching	50%.[22]	EVAR	for	
RAAA	is	a	very	difficult	and	competitive	procedure	among	vascular	emergencies,	so	it	
of	paramount	importance	the	recognition	of	pre-operative	factors	that	may	influence	
outcome	results	regarding	survival	and	complications	of	the	intervention.		
Major	hemorrhage	and	persisting	hypotension	after	rupture	seem	to	contribute	to	
the	raised	mortality	rates	and	are	believed	to	be	the	main	cause	of	 intra-operative	
death.	 [23]	 Trauma	 and	 hemorrhage	 are	 associated	 with	 coagulopathy,	 which	
nowadays	is	considered	to	be	the	consequence	of	anticoagulant	protein	C	pathway	
activation,	rather	than	the	consumption	as	highlighted	in	earlier	studies.	[24,25,28,29]	
Even	if	patients	survive	intra-operative	danger,	post-operative	mortality	remains	high	
due	to	the	complications	following	rupture,	such	as	multiple	organ	failure,	myocardial	
infarction,	 and	 thromboembolism.	 A	 possible	 contributing	 mechanism	 for	 these	
complications	is	an	imbalance	between	the	activation	of	the	coagulation	system	and	
the	fibrinolytic	system.		
The	 coagulation	 system	 is	 activated	 in	 patients	 with	 RAAA	 and	 shock,	 and	 the	
development	of	coagulopathy	predicts	poor	outcome.	Acute	traumatic	coagulopathy	
is	 the	 failure	 of	 coagulation	 homeostasis,	 arising	 rapidly	 after	 traumatic	 injury,	
hemorrhage,	and	shock.	[28,29]	Prolonged	prothrombin	time,	degree	of	fibrinolysis,	
depletion	of	coagulation	factors	and	inhibitors,	and	general	failure	of	the	blood	have	
all	been	identified	as	being	primary	indicators	for	acute	traumatic	coagulopathy.	[26]	
There	 are	 reports	 in	 literature,	 dating	 back	 in	 early	 1990s,	 that	 investigated	 pre-
operative	 coagulopathy	 in	 RAAAs.	 Davies	 MJ	 et	 al	 concluded	 in	 their	 study,	 that	
patients	with	reduced	platelet	count	(<100	x	109/L)	or	a	prothrombin	time	>	1.5	times	
the	control	value,	had	significantly	higher	mortality	rates	when	compared	to	patients	
with	 normal	 screening	 results	 (p<0.001).	 These	 findings	 may	 indicate	 that	
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coagulopathy	 at	 the	 time	 of	 admission	 predicts	 poor	 outcome	 in	 patients	 with	
ruptured	aortic	aneurysm.	[23]	Another	study	in	the	early	days	of	rEVAR,	found	that	
continued	hemorrhage	caused	 thrombocytopenia	at	 the	end	of	 the	 surgery,	which	
resulted	in	increased	post-operative	morbidity	and	mortality	rates.	[27]	Later,	other	
studies	investigated	the	role	of	coagulopathy	in	RAAA	and	concluded	that	the	majority	
(85%)	of	RAAAs	do	not	present	with	coagulopathy	and	in	those	that	do	so,	significant	
coagulopathy	 is	 limited	 to	 only	 6%.	 [25]	 Other	 reports	 examined	 the	 potential	
association	between	emergency	department	 coagulation	profile	and	outcome,	and	
found	 no	 significant	 differences	 in	 PT,	 APTT,	 platelet	 count	 between	patients	who	
survived	 and	 those	 who	 died,	 therefore	 coagulation	 profile	 is	 not	 a	 predictor	 of	
outcome	in	RAAAs.	[30]	No	statistically	significant	correlation	between	preoperative	
coagulopathy	 and	 mortality	 was	 found	 in	 another	 study	 in	 2016,	 although	 a	
significantly	greater	degree	of	postoperative	coagulopathy	was	seen	among	patients	
who	died	both	within	24-h	and	30	days	postoperatively.	[31].	As	far	as	fibrinogen	is	
concerned,	 low	 preoperative	 fibrinogen	 concentration	 was	 significantly	 associated	
with	preoperative	hypotension	and	increased	intraoperative	bleeding	in	patients	with	
RAAA.	 [32]	 RAAA	 repair	 is	 associated	 with	 inhibition	 of	 systemic	 fibrinolysis	 and	
intense	thrombin	generation.	Similar	changes	are	seen	in	non-ruptured	AAA	but	are	
of	a	lesser	magnitude.	This	procoagulant	state	may	contribute	to	the	microvascular	
and	macrovascular	 thrombosis	 that	 leads	 to	myocardial	 infarction,	multiple	 organ	
failure,	and	thromboembolism.	[34]	A	hyperfibrinolytic	state	was	reinforced	by	shock,	
however,	the	clinical	outcome	with	a	relatively	high	incidence	of	thrombosis-related	
deaths,	indicate	a	prothrombotic	state	instead	of	a	hyperfibrinolytic	state	as	a	major	
end-point	of	attention	in	patients	with	shock	as	a	result	of	a	RAAA.	[33]		
Transfusion	 in	 trauma	 and	 in	 shock	 patients,	 has	 been	 according	 to	 practice	
guidelines.	 [35,36]	 Proactive	 administration	 of	 PLT	 and	 Fresh	 Frozen	 Plasma	 (FFP)	
improves	 coagulation	 competence,	 reduces	 postoperative	 hemorrhage,	 increases	
survival	 in	massively	 bleeding	RAAA	patients	 and	 smaller	 FFP/RBC	 ratios	 (RBC:	 red	
blood	 cells)	 and	 larger	 volumes	 of	 crystalloid	 infusion	 were	 associated	 with	
development	of	 coagulopathy	 and	poorer	prognosis	 of	 survival.	 [31,37]	 In	 another	
study,	EVAR	patients	treated	with	massive	transfusion	(MT)	had	lower	FFP/RBC	and	
PLT/RBC	ratios	than	OR	patients	with	MT	for	RAAA.	[38]	
In	this	small	series	analysis,	we	attempted	to	investigate	the	association	between	
presenting	coagulation	screening	and	outcome	in	patients	undergoing	EVAR	for	RAAA.	
Fibrinogen	levels	and	PLT	count	on	admission	seemed	to	be	significantly	associated	
with	better	chances	of	30-day	survival	and	fewer	endoleaks	rates.	The	latter	was,	also	
influenced	by	lower	INR	levels.	Only,	higher	presenting	PLT	count	may	be	predictive	
of	overall	survival	in	these	patients.	Coagulation	profile	failed	to	predict	MACE	during	
follow-up	period.	Lastly,	patients	who	underwent	aneurysm-related	re-intervention,	
presented	with	prolonged	INR	values.	
The	present	study	has	certain	 limitations.	 It	 is	a	 retrospective	study	 that	 suffers	
from	 small	 numbers.	 This	 kept	 us	 from	using	 important	 analysis	methods,	 such	 as	
logistic	regression.	Nevertheless,	this	is	an	important	pilot	study	and	the	results	should	
be	taken	into	account	for	future	and	larger	studies.	
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Conclusion	
In	conclusion,	higher	fibrinogen	levels	and	PLT	count	on	admission,	which	may	indicate	
a	preoperative	hypercoagulable	and	prothrombotic	profile	may	be	associated	with	
better	 chances	 of	 early	 survival	 in	 RAAA	 patients	 undergoing	 EVAR.	Whether	 the	
outcome	of	these	patients	can	be	improved	by	technically	increasing	fibrinogen	levels	
through	proactive	administration	of	plasma,	FFP	or	other	blood	products,	as	soon	the	
diagnosis	of	RAAA	is	made,	remains	to	be	seen.	
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